RefinedPractice
News Release: Fighting Superbugs
6 July 2011
A new report today by the Office of Health Economics (OHE) called for a shake up in the way future antibiotics are to be rewarded in…
Workshop on Responding to Value-Based Pricing
6 June 2011
Register now for our workshop on ‘value-based pricing’, how it relates to risk-sharing and patient access schemes and what approaches might make the most sense.
Drugs and Vaccines for Developing Countries
1 June 2011
Forthcoming in the Oxford Handbook on the Economics of the Biopharmaceutical Industry, this paper describes the context of the problem of access to medicines in developing…
Measuring Value with Pharmacoeconomics
26 May 2011
In forthcoming chapter in the Oxford Handbook on the Economics of the Biopharmaceutical Industry, experts in the field outline the evolution of cost-effectiveness analysis (CEA) through…
OHE is Moving its Offices
23 May 2011
On 31 May, OHE will be moving its offices to Southside, 7th Floor, 105 Victoria Street, London SW1E 6QT. Telephone/fax numbers and e-mails will remain the…
QALYs v. Other Criteria in NHS Decisions
17 May 2011
Just released is an OHE Research Paper that examines whether and how decisions about allocating resources for health care differ across the NHS and, particularly, in…
Effects of Public and Charitable Research Funding
20 April 2011
Released today is an OHE study commissioned by Cancer Research UK that explores the interdependence between publicly funded and charity funded medical research. In particular, the…
Incorporating Multiple Criteria in HTA
19 April 2011
This OHE publication is intended to inform and stimulate debate about the way different sorts of evidence and considerations are taken into account in decisions about…
New: Antimicrobial Drug Incentives
6 April 2011
Antimicrobial resistance (AMR) is becoming a major global public health threat. In this new OHE Research Paper, the authors identify barriers to the development of new…